HC reserves order on Natco's plea over patent for Novartis drug

Natco has argued before Justice C Hari Shankar against the grant of patent by IPO to the pharmaceutical composition comprising combination of sacubitril + valsartan as a sodium salt complex of the Vymada.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cgefB6C
via IFTTT